/

Other

/

Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc.

Verified Nov 2026

Other

·

United States flag

Irvine, California

·

Since 2017

Tarsus Pharmaceuticals is a biopharmaceutical company headquartered in Irvine, California, founded in 2017, with 200–500 employees and estimated revenue of $250–500 million. The company develops and commercializes eye care treatments, including its FDA-approved product XDEMVY® for Demodex blepharitis, and maintains a pipeline addressing ocular rosacea, Lyme disease, and other conditions using its proprietary lotilaner platform.

Tarsus Pharmaceuticals, Inc.

Verified Nov 2026

AT A GLANCE

Founded

2017

Headquarters

United States flag

Irvine, California

Employees

200-500

Ownership

Tarsus Pharmaceuticals, Inc. at a glance

Revenue

$250-500M

Est. band

Employees

200-500

Founded

2017

Headquarters

Irvine, California

Industries

Automotive

Electric Vehicles

Medical

Overview

Tarsus Pharmaceuticals is a biopharmaceutical company headquartered in Irvine, California, founded in 2017, with 200–500 employees and estimated revenue of $250–500 million. The company develops and commercializes eye care treatments, including its FDA-approved product XDEMVY® for Demodex blepharitis, and maintains a pipeline addressing ocular rosacea, Lyme disease, and other conditions using its proprietary lotilaner platform.

At a glance

Attribute

Detail

Founded

2017

Headquarters

Irvine, California

Employees

200-500

Revenue

$250-500M (estimated)

What Tarsus Pharmaceuticals, Inc. makes

The company specializes in drug development and commercialization for eye diseases, leveraging a proprietary therapeutic platform targeting parasite-mediated conditions.

Latest developments

Facilities

Tarsus Pharmaceuticals, Inc. is headquartered in Irvine, California. Public sources also reference these locations:

Company details

Tarsus reported record sales for XDEMVY® in the third quarter of 2026, serving patients, healthcare providers, and specialty pharmacies. Tarsus Pharmaceuticals, Inc. was founded in 2017, has an estimated 200-500 employees, and is headquartered in Irvine, California.

Frequently asked questions

What does Tarsus Pharmaceuticals, Inc. do?

Tarsus Pharmaceuticals is a biopharmaceutical company headquartered in Irvine, California, founded in 2017, with 200–500 employees and estimated revenue of $250–500 million. The company develops and commercializes eye care treatments, including its FDA-approved product XDEMVY® for Demodex blepharitis, and maintains a pipeline addressing ocular rosacea, Lyme disease, and other conditions using its proprietary lotilaner platform.

Where is Tarsus Pharmaceuticals, Inc. headquartered?

Tarsus Pharmaceuticals, Inc. is headquartered in Irvine, California (15440 Laguna Canyon Road, Irvine, California, 92618).

When was Tarsus Pharmaceuticals, Inc. founded?

Tarsus Pharmaceuticals, Inc. was founded in 2017.

How big is Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. has an estimated 200-500 employees, with revenue in the $250-500M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Irvine, California (HQ)Headquarters · United States
Irvine, California (HQ)15440 Laguna Canyon Road, Irvine, California, 92618, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.